BNP Paribas Financial Markets’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,999
| Closed | -$504K | – | 4257 |
|
|
2020
Q4 | $504K | Sell |
6,999
-1,638
| -19% | -$85.7K | ﹤0.01% | 2455 |
|
|
2020
Q3 | $394K | Buy |
8,637
+5,775
| +202% | +$241K | ﹤0.01% | 2363 |
|
|
2020
Q2 | $129K | Sell |
2,862
-14,206
| -83% | -$637K | ﹤0.01% | 2665 |
|
|
2020
Q1 | $657K | Buy |
17,068
+4,776
| +39% | +$220K | ﹤0.01% | 2197 |
|
|
2019
Q4 | $569K | Buy |
12,292
+3,346
| +37% | +$145K | ﹤0.01% | 2379 |
|
|
2019
Q3 | $364K | Buy |
8,946
+680
| +8% | +$29.4K | ﹤0.01% | 2379 |
|
|
2019
Q2 | $398K | Sell |
8,266
-2,540
| -24% | -$134K | ﹤0.01% | 2144 |
|
|
2019
Q1 | $677K | Buy |
10,806
+6,907
| +177% | +$474K | ﹤0.01% | 1906 |
|
|
2018
Q4 | $233K | Buy |
3,899
+2,825
| +263% | +$170K | ﹤0.01% | 2046 |
|
|
2018
Q3 | $69.2K | Sell |
1,074
-2,518
| -70% | -$141K | ﹤0.01% | 2924 |
|
|
2018
Q2 | $162K | Sell |
3,592
-11,582
| -76% | -$462K | ﹤0.01% | 2545 |
|
|
2018
Q1 | $471K | Buy |
15,174
+2,311
| +18% | +$76K | ﹤0.01% | 2255 |
|
|
2017
Q4 | $385K | Sell |
12,863
-2,376
| -16% | -$68.8K | ﹤0.01% | 2622 |
|
|
2017
Q3 | $503K | Buy |
15,239
+6,838
| +81% | +$237K | ﹤0.01% | 1991 |
|
|
2017
Q2 | $281K | Buy |
8,401
+2,540
| +43% | +$75.8K | ﹤0.01% | 2234 |
|
|
2017
Q1 | $170K | Sell |
5,861
-406
| -6% | -$10.1K | ﹤0.01% | 2291 |
|
|
2016
Q4 | $140K | Buy |
6,267
+2,383
| +61% | +$46.6K | ﹤0.01% | 2389 |
|
|
2016
Q3 | $72.1K | Buy |
3,884
+2,877
| +286% | +$54.3K | ﹤0.01% | 2263 |
|
|
2016
Q2 | $16.4K | Buy |
1,007
+954
| +1,800% | +$14K | ﹤0.01% | 2673 |
|
|
2016
Q1 | $619 | Sell |
53
-5,259
| -99% | -$58.8K | ﹤0.01% | 2543 |
|
|
2015
Q4 | $62K | Sell |
5,312
-762
| -13% | -$9.64K | ﹤0.01% | 2651 |
|
|
2015
Q3 | $74.3K | Buy |
6,074
+3,824
| +170% | +$48.8K | ﹤0.01% | 2587 |
|
|
2015
Q2 | $21.2K | Buy |
2,250
+1,635
| +266% | +$15.1K | ﹤0.01% | 3007 |
|
|
2015
Q1 | $5.44K | Buy |
+615
| New | +$6.21K | ﹤0.01% | 3106 |
|
|
2014
Q4 | – | Sell |
-1,588
| Closed | -$10.7K | – | 4104 |
|
|
2014
Q3 | $10.7K | Buy |
1,588
+1,230
| +344% | +$8.63K | ﹤0.01% | 3554 |
|
|
2014
Q2 | $2.57K | Hold |
358
| – | – | ﹤0.01% | 2958 |
|
|
2014
Q1 | $2.84K | Hold |
358
| – | – | ﹤0.01% | 2561 |
|
|
2013
Q4 | $2.84K | Buy |
+358
| New | +$3.34K | ﹤0.01% | 3461 |
|
Other funds holding BEAT
BNP Paribas Financial Markets's BEAT Position: Q1 2021 in Review
BNP Paribas Financial Markets sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 6,999 shares — an estimated $504K sold.
BNP Paribas Financial Markets first reported a position in BEAT in Q4 2013 and held it in 28 quarters. The position peaked at $677K in Q1 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- BNP Paribas Financial Markets reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- BNP Paribas Financial Markets sold 6,999 BioTelemetry, Inc. shares in Q1 2021, an estimated $504K.
- BNP Paribas Financial Markets first reported a position in BioTelemetry, Inc. in Q4 2013 and held it in 28 quarters.
- BNP Paribas Financial Markets's BioTelemetry, Inc. position peaked at $677K in Q1 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2021, filed 7 May 2021.